Full-Time

Director of Product Management

Oncology

Confirmed live in the last 24 hours

BillionToOne

BillionToOne

201-500 employees

Molecular diagnostics for prenatal and oncology testing

Biotechnology
Healthcare

Compensation Overview

$204k - $229.5kAnnually

+ Equity Options + Corporate Bonus Program

Senior, Expert

Menlo Park, CA, USA

Hybrid position requiring onsite presence 3 days a week; relocation to SF Bay Area required.

Category
Product Management
Product
Required Skills
Product Management

You match the following BillionToOne's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • 5-10 years of product management experience with demonstrated end-to-end ownership of complex product lines
  • Proven experience launching diagnostic testing products (oncology or NGS-based diagnostics preferred)
  • GM-like mindset with strategic vision and hands-on execution skills
  • Excellent people management and leadership capabilities across cross-functional teams
  • Strong background in product launch strategy, go-to-market execution, and program management
  • On-site position (relocation to SF Bay Area required)
Responsibilities
  • Own the oncology product line from top to bottom, ensuring long-term strategic success while handling day-to-day tactical responsibilities
  • Be the company’s leading expert on user needs, market trends, and how BillionToOne’s technology can solve critical problems in oncology diagnostics
  • Lead product launch strategies, overseeing every element from assay development to software apps, regulatory constraints, and customer experience
  • Manage and inspire a cross-functional team of R&D, clinical, engineering, and commercial experts, aligning their efforts towards the product’s success
  • Design and deliver a seamless user experience across the entire testing process, in collaboration with UX designers and stakeholders
  • Monitor product performance, user feedback, and market shifts, making data-driven decisions to enhance product offerings and maintain leadership in the market
Desired Qualifications
  • Another advanced degree (Masters/PhD) in molecular biology, bioengineering, medicine, chemical biology, or a related field is strongly preferred
  • Experience with launching and managing NGS-based diagnostic testing assays is a strong plus

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne's business model centers on providing these diagnostic services directly to healthcare providers, generating revenue through the sale of testing services that inform treatment decisions. The goal of BillionToOne is to enhance the accuracy, efficiency, and accessibility of molecular testing, driven by a commitment to growth, equality, and teamwork in making a positive impact on healthcare.

Company Stage

Series D

Total Funding

$380.2M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

1%

1 year growth

-1%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • BillionToOne achieved over 100% revenue growth, reaching $153 million in 2024.
  • The company secured a billion-dollar valuation with a $130 million funding round.
  • Expansion in Austin, Texas, will create 1,000 jobs and increase production capacity.

What critics are saying

  • Emerging startups in molecular diagnostics could erode BillionToOne's market share.
  • Rapid technological advancements require continuous innovation to maintain competitiveness.
  • Economic instability in target markets may affect product affordability and adoption.

What makes BillionToOne unique

  • BillionToOne's QCT technology detects DNA variations at single base-pair resolution.
  • Their non-invasive prenatal tests replace risky procedures like amniocentesis.
  • Northstar products offer precise therapy selection and monitoring for oncology patients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging